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ABSTRACT
Background Paediatric chronic fatigue syndrome (CFS)/
myalgic encephalomyelitis (ME) is relatively common and
disabling. Research is hampered because current patient-
reported outcome measures (PROMs) do not capture
outcomes that are important to children with CFS/ME.
Aim The aim of this study was to explore the aspects of
life and health outcomes that matter to children with
CFS/ME.
Methods Twenty-ﬁve children with CFS/ME were
interviewed (11 males, 14 females; mean age 12.9 years
(SD 2.2), range 8–17). Twelve were trial participants
interviewed during the trial and 13 were recruited as
part of a follow-up qualitative study. Parents were
present in 19 interviews with their children. Three
mothers participated in a focus group. All the interviews
and the focus group were audio-recorded and
transcribed. Data were analysed thematically using
techniques of constant comparison. NVivo was used to
structure and categorise data in a systematic way.
Results Children identiﬁed four key themes (health
outcome domains): ‘symptoms’ that ﬂuctuated, which
caused an unpredictable reduction in both ‘physical
activity’ and ‘social participation’ all of which impacted on
‘emotional well-being’. These domains were inﬂuenced by
both ‘management’ and ‘contextual factors’, which could
be positive and negative. The relationship between
healthcare and school was considered pivotal.
Conclusions Children’s descriptions helped to inform a
conceptual model that is necessary to develop a new
paediatric CFS/ME PROM. Doctors need to be aware of
how children conceptualise CFS/ME; the relationship
between healthcare and school is fundamental to
ameliorate the impact of CFS/ME.
Trial registration number ISRCTN81456207.
INTRODUCTION
Chronic fatigue syndrome/myalgic encephalomyeli-
tis (CFS/ME) is characterised by severe disabling
fatigue1 with additional symptoms including mus-
culoskeletal pain, sleep disturbance, cognitive dys-
function, headaches, dizziness and sweats.2
Paediatric CFS/ME is relatively common with a
prevalence of between 0.4% and 2.4%3–6 in popu-
lation studies and between 0.06% and 0.1%7 8 in
studies based in hospital settings. It is disabling9–11
with a negative impact on quality of life.9–16
Despite this, research is hampered by the lack of
high-quality patient-reported outcome measures
(PROMs) for adults17 and children.18
Well-developed PROMs enable clinicians and
researchers to collect patient-centred evidence on
outcome.19 20 PROM development starts with a
patient-derived conceptual framework that deﬁnes
the key outcomes to be measured.21–23 Qualitative
exploration of the outcomes that really matter to
children with CFS/ME is limited.18 This paper
describes the combined results from two studies
describing the aspects of life and health outcomes
that really matter to children with CFS/ME.
METHODS
Participants
Children with CFS/ME were recruited into two
separate studies through a large regional specialist
CFS/ME service in South West England by their
specialist clinician. Children were eligible if they
were diagnosed with CFS/ME using the National
Institute for Health and Care Excellence criteria,2
mildly to moderately affected (not housebound)
and able to understand the patient information
sheets. Consecutive children were approached to
take part in the Specialist Medical Intervention and
Lightning Evaluation (SMILE) trial from September
2010 to December 2011 and PROMS study from
Open Access
Scan to access more
free content
What is already known on this topic
▸ Chronic fatigue syndrome/myalgic
encephalomyelitis (CFS/ME) is an important
disabling illness in childhood.
▸ Children with CFS/ME attend less school and
can have mood problems.
▸ There is currently a lack of qualitative evidence
describing important outcomes to children with
CFS/ME.
What this study adds
▸ Children with CFS/ME report a range of often
extreme impacts on their health and ability to
participate in school and society.
▸ A new patient-reported outcome measure for
paediatric CFS/ME should measure symptoms,
their impact on physical activities, participation
in school and social activities, and mood.
▸ Supportive schools, family and friends and
strategies to manage activity can help
ameliorate symptoms.
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June to August 2012 in assessment and follow-up clinics. If eli-
gible, they were informed about the relevant study by their spe-
cialist clinician and given patient information sheets. Consent
was obtained from the family to be contacted by a researcher to
arrange an interview.
SMILE trial
Children (aged 12–18 years) and their parents were interviewed
as part of the SMILE trial about whether PROMs used were suit-
able to assess the impact of CFS/ME and measure important out-
comes.24 25 Children and their mothers were interviewed at three
possible time points using a checklist of topics24 25 usually at the
participants’ homes. Purposive sampling ensured interviews
included a range of informants, in terms of age, sex and families
from both intervention arms (maximum variation sampling).24 25
PROMs study
We then extended this work in a further qualitative study
recruiting participants from a wider age range (aged 8–18 years)
to explore the key health outcomes important in paediatric
CFS/ME (PROMs study). Semistructured interviews in partici-
pants’ homes were used to explore how children with CFS/ME
describe the impact of CFS/ME. A topic guide (see online sup-
plementary appendix 1) informed by previous reviews17 26 was
sent in advance to children and their parents before the inter-
view. We conducted one focus group for parents (without their
child) to discuss aspects of quality of life that they felt were
important.
Data collection and analysis
Qualitative data
For both studies, interviews were recorded and transcribed ver-
batim. Data analysis was an ongoing and iterative process.
Interviews were stopped when we reached data saturation. We
compared data collected from both studies for systematic differ-
ences in content before combining the data. Data were analysed
thematically using techniques of constant comparison.27 Data
items were systematically assigned codes using NVivo.28 Similar
codes were cross-referenced and emerging themes were dis-
cussed with members of the research team to improve reliability.
Two members of the research team independently analysed
approximately 10% of the data to compare coding and enhance
reliability. Descriptive accounts were produced, and theoretical
explanations for behaviours, opinions and decisions developed.
Quantitative data
The service currently collects information routinely at assessment
about fatigue, physical functioning, pain, anxiety and depression
from the following inventories: Chalder Fatigue Scale,29 36-item
short form (SF-36) physical function subscale,30 EQ-5D,31 visual
analogue pain rating scale, Hospital Anxiety and Depression
Scale32 and the Spence Children’s Anxiety Scale.33
RESULTS
Participants
Twenty-ﬁve children with CFS/ME were interviewed (11 males,
14 females; mean age 12.9 years (SD 2.2), range 8–17). Twelve
(of the 15 approached) were interviewed during the SMILE trial
and 13 (of the 17 approached) were recruited as part of the
PROMs study. Parents were present with their child during 19/
25 interviews. Twenty-ﬁve mothers were interviewed.
Table 1 compares those interviewed with those assessed in the
specialist CFS/ME service in the same time period. Participants
in the PROMs study were slightly younger. Participants were
also less anxious and less likely to be female because we pro-
spectively recruited male patients (38.5% compared with
72.6%, p=0.01). Initial clinical assessment data were available
for 5/7 of the children who declined to participate. Analysis of
these data shows that children who declined were broadly
similar to those who participated in terms of the characteristics
shown in table 1: mean (SD) age 14.4 (1.5) years; 80% (4/5)
female; median (IQR) time to assessment 6 (6–10) months;
median (IQR) Chalder Fatigue score 23 (22–25); median (IQR)
SF-36 physical function 65 (60–80).
Living with CFS/ME—‘feeling ill’
We propose a conceptual model (ﬁgure 1) of being unwell with
CFS/ME that suggests interactions between four key themes
(health outcome domains) that contribute to how children
understand their illness and ‘feeling ill’: ‘symptoms’, ‘physical
activity’, ‘social participation’ and ‘emotional well-being’. These
were inﬂuenced by two additional themes: ‘management’ and
‘contextual factors’. Children described a linear relationship
between symptoms, impact on activity, participation and emo-
tional well-being. When symptoms were worse, children felt this
had a direct impact on their activity, “When I am worse it is
mostly just resting”, and mood, “As I feel crash down I become
a little bit less positive”. Children also described mood effects as
a result of a lack of participation, “I could have been doing
better and it is very frustrating”.
Symptoms
Most children described a range of symptoms: aches and pain,
sleep disturbances, a lack of energy, tiredness and memory and
concentration problems. Although the individual experience of
symptoms differed, some described a collection of symptoms,
“everything hurts”.
My legs felt like jelly, which was the cause of the …and um I got
a sore throat, … um I got ear pain, headache, tummy ache, every-
thing. (Female)
Several children described the cognitive impact; a reduced
capacity to remember things, concentrate and a ‘brain fog’. This
was often described as a ‘loss’ in ability to participate in aca-
demic activities:
I was just good at memorising stuff and now it’s completely
gone. (Female)
Fluctuation in symptoms
Many children described the unpredictable ﬂuctuation in symp-
toms and an associated lack of control, often describing a boom
and bust cycle. This was particularly linked to their perceived
levels of energy “ever changing energy level” and impacted their
mood and conﬁdence in returning to usual activities:
I’d like to do some certain sports again, but I am just worried
about the energy levels…. (Male)
Physical activity
All participants described a reduction in physical activity and
children often reﬂected on sport or hobbies that they had to
give up, “used to be very sporty and active” (male). In some
cases, symptoms stopped children doing activities at the time, in
others, restricting activity led to a negative cycle of more and
more limitation:
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I just dropped things and dropped things…so it is kind of a bit of
a negative cycle and was going down, and down until I was liter-
ally doing nothing. (Female)
A few children acknowledged the consequences of not limit-
ing activity resulting in ‘paying the price’:
I organised a massive water ﬁght the other day and I think I over
did it a bit so yesterday I was inside all day, I just felt wiped out.
(Male)
Social participation
Impact on school
Reduced school attendance and reduced timetables “I only do
little amounts of school” was one of the most commonly
reported consequences. Time off school varied from “two hours
a day” to “a year off school”. Children were worried about
exams, falling behind and losing out on social interaction:
it’s not just the lessons I’m missing out on, it’s the other stuff
that’s kind of there. (Female)
Returning to school was found to be quite challenging by
children, “It was actually quite hard to get back to school”.
Children and their parents (box 1) reported anxiety caused by
not keeping up with schoolwork. In some cases, children
dropped subjects to reduce stress. In many cases, children were
frustrated at not meeting their full potential:
I get really frustrated because then I think if I was there full time
I could have been in more lessons and I could have been doing
better. (Female)
Impact on friendships
Despite parental encouragement, being unwell with CFS/ME
affected children’s ability and motivation to spend time with
friends, often limited due to symptoms and reduced activities:
It was hard because like my friends were going out and leaving
me at home because I just couldn’t do it. (Female)
Impact on home life and family
A few children reported that CFS/ME affected their ability to
spend time with their relatives or siblings, going on family
outings or on holiday. Parents emphasised the impact it had on
Table 1 Comparison of characteristics of children at initial clinical assessment who were interviewed as part of the SMILE trial and PROMs
study compared with children who were assessed and treated by the specialist service during the same period (2010–2012)
SMILE trial PROMs study
Study sample
(n=13*) unless
otherwise shown
CFS cohort (n=511)
unless otherwise
shown p Value†
Study sample
(n=13) unless
otherwise shown
CFS cohort (n=530)
unless otherwise
shown p Value†
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years)‡ 14.5 (1.5) 14.0 (1.6) 0.21 11.3 (2.7) 13.7 (1.9) <0.001
Female 10 (76.9%) 387 (75.7%) 0.92 5 (38.5%) 385 (72.6%) 0.01
n Median (Q1–Q3) n Median (Q1–Q3) n Median (Q1–Q3) n Median (Q1–Q3)
Time to assessment
(months)
12 12 (6–17) 421 12 (8–24) 0.40 9 8 (6–12) 438 12 (8–24) 0.07
Chalder Fatigue score
(0–33)
13 26 (23–28) 479 26 (22–29) 0.78 13 24 (17–25) 491 25 (22–28) 0.07
SF-36 physical function
(0–100)
13 50 (45–55) 469 55 (35–70) 0.96 11 50 (30–75) 484 50 (30–70) 0.85
Anxiety (SCAS) (0–90) 12 45 (21–58) 449 30 (18–45) 0.12 10 16 (8–26) 465 29 (17–43) 0.01
No. of symptoms
(0–14)
13 9 (7–10) 575 8 (7–10) 0.52 13 8 (7–10) 528 8 (6–10) 0.91
Anxiety (HADS) (0–21) 13 12 (8–15) 475 9 (6–12) 0.09 8 7 (4–9) 435 8 (5–12) 0.23
Depression (HADS)
(0–21)
12 9 (7–11) 478 8 (5–10) 0.10 8 7 (2–9) 438 7 (2–9) 0.31
Visual analogue pain
(0–100)
12 42 (29–57) 461 57 (24–73) 0.28 12 61 (46–81) 476 57 (24–73) 0.24
School attendance
past week n=13 n=541 n=13 n=559
None 0 (0.0%) 101 (21.2%) 0.24 4 (30.8%) 104 (21.0%) 0.57
10% 2 (15.4%) 49 (10.3%) 0 (0.0%) 53 (10.7%)
20% 2 (15.4%) 29 (6.1%) 1 (7.7%) 37 (7.5%)
40% 1 (7.7%) 88 (18.5%) 0 (0.0%) 88 (17.7%)
60% 3 (23.1%) 100 (21.0%) 3 (23.1%) 95 (19.2%)
80% 3 (23.1%) 84 (17.6%) 4 (30.7%) 89 (17.9%)
100% 2 (15.4%) 21 (4.4%) 1 (7.7%) 26 (5.4%)
Not applicable 0 (0.0%) 5 (1.1%) 0 (0.0%) 4 (0.8%)
*Characteristics included for one child whose mother was interviewed (the child was not interviewed).
†χ2 tests for proportions, Kruskal–Wallis test for continuous measures.
‡Age for the SMILE study and the CFS cohort is age at first assessment. Age for the PROMs study is age at interview. This is because children were recruited from follow-up visits not at
clinical assessment.
CFS, Chronic Fatigue Syndrome; HADS, Hospital Anxiety and Depression Scale; PROMs, patient-reported outcome measures; SCAS, Spence Children’s Anxiety Scale; SMILE, Specialist
Medical Intervention and Lightning Evaluation.
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family life with the family having to work around the ﬂuctuating
symptoms:
There aren’t a lot of family days out…I really miss them.
(Female)
Emotional well-being
Children and their parents described a fear and anxiety asso-
ciated with having the illness. This was often related with the
ﬂuctuation and uncertainty about the duration of periods of
feeling ill:
…I was so scared of it lasting a long time again. (Female)
Activity restrictions often led directly to feelings of low mood
and frustration. Parents noted that the loss of social interaction
affected their child’s morale.
aaaah, it’s a bit annoying and stressful, um I’m not always able to
do what I want to do. (Male)
Management (self and therapeutic)
Children and their parents described a variety of management
strategies for their CFS/ME. Some of these were described as
strategies they had learnt ‘naturally’ or on their own through
experience (self ):
I actually kind of naturally did quite a good balance between
doing enough but not doing too much. (Female)
In other cases, children described managing activity using
similar descriptions as used in the specialist service
(therapeutic):
…I just have to save a bit of energy up for it it’s like money you
have to save a bit, spend a bit. (Male)
Parents reinforced that important activities such as having a
job were often adapted to minimise the impact of the illness.
Where children had managed to continue with some activity,
these were sometimes prioritised if they were particularly enjoy-
able although often limited to prevent an increase in symptoms.
Contextual factors
Contextual factors, such as support and understanding from
family, friends, school and healthcare providers, inﬂuenced their
ability to manage their illness. Friends were often willing to
undertake less physical activities indoors, “We just invite them
in and watch a movie or whatever”. However, CFS/ME was
often perceived as illegitimate and participants talked about the
negative attitudes and comments they received.
I am more happy to be in the sanctuary of my own home where
my parents understand me than people at school who don’t
really have a clue. (Male)
Parents were more concerned about the impact on their
child’s emotional well-being than children themselves. Some
parents talked about a lack of understanding from extended
family members, “Grandparents they don’t understand”. Some
children reported signiﬁcant support from schools enabling
them to manage their symptoms:
…they have offered the best help they can get me as well, time
off resting, if I am feeling ill I can go straight to the nurses’ ofﬁce
and lie down. (Male)
However, others reported difﬁculties in having their condition
recognised and appropriately supported by educational author-
ities. Parents and children described the importance of getting a
diagnosis and being understood, “Relief really to be under-
stood”. The interaction between healthcare and educational
institutions was fundamental to acknowledge the condition and
Figure 1 A child’s experience of living with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a conceptual model.
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manage the impact. A mother and daughter described the inter-
action between a delayed diagnosis, lack of support from
schools and impact on the daughter:
Mother: …I was trying to get her off from school and they
wouldn’t let me take her from school
Child: it was really annoying.
Mother: …she was really struggling and then it wasn’t, until she
was diagnosed that they said that you can only do so many
hours. (Mother and daughter)
DISCUSSION
CFS/ME was described as an unpredictable and ﬂuctuating
illness with a pervasive impact. Children described a linear rela-
tionship between four key outcomes: symptoms impacted on
physical activity, school and social activities, which affected
mood and emotional well-being. These can be ameliorated (or
not) by contextual factors such as social support from family,
friends, school and healthcare. The relationship between health-
care and school was considered pivotal.
Strengths and weaknesses
This is a large qualitative study (n=25), and participants were
representative of those assessed in a specialist service. We are
unable to generalise results for patients seen in primary care,
those who are severely affected or younger than 8 years old.
Most children chose to be interviewed with parents, which
may have caused them to conceal problems.34 To ensure the
child’s voice remained paramount, quotes from parents have
been included where they have enriched their child’s view-
points, which may mean we have not included areas that are
important to parents. Eleven children were recruited from a
trial. Trial participants can differ from those that do not take
part in a trial.35 In addition, those who took part in the
PROM study received the topic guide before the interview,
which may have inﬂuenced their results; however, these groups
and the data they generated were similar to the clinic popula-
tion and to each other.
Results in context with previous literature
Child-derived measures speciﬁc to CFS/ME do not exist.18 The
identiﬁed themes underpin a conceptual model of the lived
experience of paediatric CFS/ME, deﬁning the health outcomes
that should be assessed in children, and enhancing the relevance
and acceptability of a new CFS/ME-speciﬁc PROM. This study
supports and extends existing (largely quantitative) evidence of
the impact of CFS/ME on children’s schooling,5 36 social activ-
ities11 37–40 and emotional function.15 16 39–42 Missing school
was the most pervasive and important reported outcome in this
study; the impact was wide-ranging, inﬂuencing social relation-
ships and academic work. These effects were exacerbated when
children returned to school because of changes in their peer
group and anxiety about falling behind in their studies. Where
educational authorities and schools were supportive, the impact
of the illness was lessened.
We were surprised that most children described a linear uni-
directional relationship between symptoms, activity and mood.
Children describe anxiety, low mood and stress as a conse-
quence of their symptoms and the reduction in usual activities,
socialising and ability to keep up with school. This is consistent
with previous studies that identiﬁed the social implications of
the illness: loneliness, loss of normal adolescent life and worries
about school.16 40 42 We assessed the data for multidirectional
relationships between the domains; however, in contrast to pre-
vious studies,16 children in this study did not describe emotional
well-being having an effect on physical activity, school or socia-
lising. This may be because previous studies recruited children
with comorbid mood disorders16 who may have received cogni-
tive behavioural therapy and explored the relationship between
mood and activities.
Unlike other studies,16 children did not describe bullying but
did report that a lack of support outside the family negatively
inﬂuenced their experience of CFS/ME. This may be because
previous studies recruited adolescents with CFS/ME who were
anxious16 or after recovery.40 Children did not report strained
family relationships,11 43–45 although they did report reduced
family activities. This may be because parents were present in
interviews and the results may have been different if children
had been interviewed alone.
Box 1 Quotes from parents to support themes
Symptoms
“She’s given up what was her best subject English, because.
you know, there’s an awful lot of reading and she can’t focus to
read”. (Mother of female)
Physical activity
“She used to be active she used to run around all time”.
(Mother of female)
Impact on school
“So obviously there was apprehension from her point of view
going back to school, a different peer group because she’s in a
different group”. (Mother of female)
“She’s ended up dropping one of the subjects just to stop the
stress”. (Mother of female)
Impact on friendships
“It is very difﬁcult keeping friends on board because obviously
they don’t want to deal with the illness and they don’t want to
be around it”. (Mother of male)
Impact on family
“We’ve also tried to prioritise so yes she does still go to
Stagecoach on Saturday. Even if that means that the whole of
the rest of the family have to work around that’s when her
energy is used”. (Mother of female)
Emotional well-being
“I also see how by her not going out, how that affects her
morale as well”. (Mother of female)
Management
“… she’d also got herself a job. Um, again just 12 hours a
week, so 4 hours, um, stint, um, in the evenings spaced out
every other day because we were thinking about her activity
levels”. (Mother of female)
“If friends come over for two hours it’s a really positive
experience if friends stay for two and a half hours its turns into
a negative experience”. (Mother of male)
Contextual factors
“He’s had all sort of comments whilst he’s been at school
about being a skiver and all the rest of it so he’s had to deal
with that”. (Mother of male)
“I mean I… I don’t feel very supported by the school. Yeah.
Um, at all really. I mean they basically just let her come and go
as she likes. Um, with very little sort of thought about how she
could be helped”. (Mother of female)
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Implications
Paediatricians need to be aware that from a child’s perspective
CFS/ME is more than just fatigue; it impacts on activity, school
attendance, socialising and mood. Contextual factors are
important in how children experience symptoms and disability.
Doctors need to develop strong relationships with schools.
Current PROMs used for CFS/ME measure fatigue, disability
and mood. A new PROM needs to collect data on symptoms,
activity and socialising. Most of these themes are not currently
assessed by PROMs used in paediatric CFS/ME.18 Future
research should explore which outcomes are most important to
children to include in a new PROM. The conceptual model is
informative for clinicians and researchers who often have differ-
ent views from children on what is important to measure46 in
research and healthcare settings.47
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